Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion type Assertion NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_head.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion wasGeneratedBy ECO_0000203 NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_provenance.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion wasDerivedFrom befree-20140225 NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_provenance.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion SIO_000772 19738092 NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_provenance.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion evidence source_evidence_literature NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_provenance.
- NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_assertion description "[To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprotease [SERPINA1], angiotensin-converting enzyme [ACE], glutathione S-transferase [GSTP1], mannose-binding lectin 2 [MBL2], and transforming growth factor beta1 [TGFB1]) are associated with severe liver disease in patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471263.RASVYUNonwjE1aruMNYs6BGkxDG_A8f6099g6F6YeKk6o130_provenance.